Norfund, the Norwegian investment fund for developing countries, is investing USD 75 million in Mulilo Energy Holdings (Mulilo), providing new capital and taking a minority ownership position in the ...
New investors Tencent and BGF joined by all existing major shareholders Funds will advance pipeline of novel TCR-CD3 bispecifics in cancer and autoimmune disease 13 November 2025; Cambridge, England – ...
Inderes Oyj, Press release, November 13, 2025, at 9:00 am EET. Inderes’ revenue grew 13% in October 2025 and was 1.8 (1.6) MEUR. CFO ...
Global SLM leader builds on strong momentum with major customer wins, new leadership appointments, and growing demand from US-based manufacturers. STOCKHOLM, Nov. 13, 2025 (GLOBE ...
IMU Biosciences (or “the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the formation of its Scientific Advisory Board (SAB).
Press release Trifork invests in legaltech company Replik to support growth, technology, and internationalization. Copenhagen, November 13, 2025 – Trifork Group AG has entered i ...
Renowned as a global powerhouse in boating, Finland will be represented at this year’s Metstrade show with its most extensive pavilion to date. A total of 15 Finnish companies will be featured, ...
Bitget, the world’s largest Universal Exchange (UEX), has announced the official addition of LLYUSDT, MAUSDT, UNHUSDT stock index perpetual futures, expanding its range of Real World Asset (RWA) ...
Telenor announces a significant step in its Internet of Things (IoT) strategy by consolidating its Nordic IoT operations under Telenor Connexion, creating a unified global IoT powerhouse. This move ...
Accountor Software, 24SevenOffice, and Heeros, providers of financial, people, and business operations software in the Nordics, today announce the creation of Finago, uniting their businesses into one ...
Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and nine months ended September 30, 2025. All dollar amounts set out herein are in ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback